Difficulty: Medium
Average Score: 92%
Practice
Which of the following drugs is a short-acting bronchodilator used for the relief of acute bronchospasm?
Correct answer
B
Rationale
In this multiple-choice question on oxygen therapy, the correct answer is B) Ipratropium. Ipratropium is a short-acting bronchodilator that is commonly used for the relief of acute bronchospasm. It works by relaxing the muscles around the airways, making it easier to breathe during an asthma attack or COPD exacerbation.
Now, let's analyze why the other options are incorrect:
A) Montelukast is a leukotriene receptor antagonist used for the long-term control of asthma and allergic rhinitis, not for acute bronchospasm relief.
C) Beclomethasone is an inhaled corticosteroid used for the maintenance treatment of asthma and not for immediate relief of bronchospasm.
D) Theophylline is a bronchodilator that can be used for both chronic and acute asthma management, but it is not typically considered a first-line option for acute bronchospasm.
In an educational context, understanding the differences between these medications is crucial for healthcare providers managing patients with respiratory conditions. Knowing which drugs are appropriate for acute symptom relief versus long-term control helps ensure optimal patient outcomes and safety. It is important for healthcare professionals to be familiar with the pharmacology of these medications to make informed clinical decisions and provide effective patient care.
Now, let's analyze why the other options are incorrect:
A) Montelukast is a leukotriene receptor antagonist used for the long-term control of asthma and allergic rhinitis, not for acute bronchospasm relief.
C) Beclomethasone is an inhaled corticosteroid used for the maintenance treatment of asthma and not for immediate relief of bronchospasm.
D) Theophylline is a bronchodilator that can be used for both chronic and acute asthma management, but it is not typically considered a first-line option for acute bronchospasm.
In an educational context, understanding the differences between these medications is crucial for healthcare providers managing patients with respiratory conditions. Knowing which drugs are appropriate for acute symptom relief versus long-term control helps ensure optimal patient outcomes and safety. It is important for healthcare professionals to be familiar with the pharmacology of these medications to make informed clinical decisions and provide effective patient care.